HOME › DRUGS › METFORMIN HYDROCHLORIDE;SAXAGLIPTIN;DAPAGLIFLOZIN
ACTIVE SUBSTANCE / INN

METFORMIN HYDROCHLORIDE;SAXAGLIPTIN;DAPAGLIFLOZIN

Brand name(s): Qtrilmet
EMA LISTED
WITHDRAWN
Diabetes Mellitus, Type 2
ACTIVE SUBSTANCE
Metformin Hydrochloride;Saxagliptin;Dapagliflozin
REGULATORS
EMA
SPONSORS / MAH
AstraZeneca AB
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
QtrilmetAstraZeneca ABWithdrawn11/11/2019Diabetes Mellitus, Type 2

FULL INTELLIGENCE ON METFORMIN HYDROCHLORIDE;SAXAGLIPTIN;DAPAGLIFLOZIN

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →